·
Epigenetic Enzymes in Drug Discovery11th Protein Kinases in Drug DiscoveryI. Novel Approaches in Kinase Targeting
II. New Tools and Technologies in Kinase Drug Discovery
III. Kinome Selectivity and Translation to Clinical Safety
IV. Kinase Evolution & Development of Resistance to Kinase Inhibitors
6th Ubiquitin Research & Drug DiscoveryI. Advances in Ubiquitin-like Modifications
II. Ubiquitin Pathways in Neurodegenerative Disorders
III. Ubiquitin Proteasome System & Oncology
IV. Autophagy in Cancer & Metabolic Diseases
V. Epigenetic Novel Drug Targets in the Ubiquitin System
VI. Deubiquitinating Enzymes as Drug Targets
2nd Protease Inhibitors in Drug DiscoveryI. Membrane-Associated Systems
II. Medical Chemistry & Drug Design of Protease Inhibitors
III. Non-Active Site Inhibition of Proteases
IV. Protease Inhibitors in Translational Research
- Cardiovascular System
- Infectious Diseases
- Inflammatory Diseases
- Neurodegenerative Diseases
- Musculoskeletal Diseases
Epigenetic Enzymes in Drug DiscoveryI. Epigenetic Modification & Transcriptional Regulation
II. Pre-Clinical to Clinical Drug Development
III. Immunotherapy: Conversion of Mechanisms
IV. Translating & Combining Antibodies
V. Novel Therapeutic Targets and Discovery
We encourage you to
sign up for a summit pass in order to get the most comprehensive look at research and drug discovery happening in the field. In addition to scientific presentations, dedicated networking sessions will allow you to connect and form new relationships with different people in the field and from both the private and public sector.
We hope to see you there!